These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 25961835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z, Mahroo O, Bunce C, Mitry D.
    Cochrane Database Syst Rev; 2020 Jul 07; 7(7):CD009510. PubMed ID: 32633861
    [Abstract] [Full Text] [Related]

  • 3. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D, Bunce C, Charteris D.
    Cochrane Database Syst Rev; 2013 Jan 31; (1):CD009510. PubMed ID: 23440840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E.
    Cochrane Database Syst Rev; 2018 Oct 16; 10(10):CD007419. PubMed ID: 30325017
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S.
    Cochrane Database Syst Rev; 2018 Apr 18; 4(4):CD011599. PubMed ID: 29669176
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G, Curran K, Lucenteforte E, Peto T, Parravano M.
    Cochrane Database Syst Rev; 2023 Jun 27; 2023(6):CD007419. PubMed ID: 38275741
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
    Gewaily D, Muthuswamy K, Greenberg PB.
    Cochrane Database Syst Rev; 2015 Sep 09; 2015(9):CD007324. PubMed ID: 26352007
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR, Michelessi M, Virgili G.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD011234. PubMed ID: 25420029
    [Abstract] [Full Text] [Related]

  • 18. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N, Campbell C, Waugh N, Azuara-Blanco A, Maredza M, Mistry H, McAuley D, Acharya N, Aslam TM, Bailey C, Chong V, Downey L, Eleftheriadis H, Fatum S, George S, Ghanchi F, Groppe M, Hamilton R, Menon G, Saad A, Sivaprasad S, Shiew M, Steel DH, Talks JS, Doherty P, McDowell C, Clarke M.
    Health Technol Assess; 2022 Dec 24; 26(50):1-86. PubMed ID: 36541393
    [Abstract] [Full Text] [Related]

  • 19. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD.
    Cochrane Database Syst Rev; 2016 Feb 08; 2(2):CD011346. PubMed ID: 26857947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.